Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Operating Expenses | 101 | 208 | 100 | 175 | 172 |
| Operating Income | -101 | -208 | -100 | -175 | -172 |
| Other Income | 0 | -1 | -23 | -2 | 14 |
| Pre-tax Income | -101 | -209 | -123 | -176 | -158 |
| Net Income Continuous | -101 | -209 | -123 | -176 | -158 |
| Net Income | $-101 | $-209 | $-123 | $-176 | $-158 |
| EBITDA(a) | $-101 | $-208 | $-100 | $-175 | $-172 |